Manfred Rüdiger

Manfred Rüdiger

Company: Ariceum Therapeutics

Job title: Chief Executive Officer


Outlining a Best-in-class SST2 Antagonist in SCLC & a Cancer Cell DNA Targeted- Auger-Electron Approach in Solid Tumors 12:45 pm

Using Satoreotide, aka JR11, labelled with Lu, Ac or Tb in SCLC Understanding the impact of changing tracer versus changing isotope Introducing a radioactively labelled small molecule to target tumor cell DNA using Auger emittersRead more

day: Day One ESC AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.